Lysoway Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.4M
- Investors
-
4
Lysoway Therapeutics General Information
Description
Developer of a lysosomal ion research platform designed to address neurodegenerative diseases and metabolic storage disorders. The company's tool offers technological approaches to screen and develop potent modulators of lysosomal ion channels, including both lysosomal ion channels that can restore autophagic flux and resolution, as well as improve plasma membrane repair through direct activation of lysosomal exocytosis, enabling healthcare providers to treat neurodegenerative diseases with genetic defects.
Contact Information
Website
www.lysoway.comCorporate Office
- 125 Cambridgepark Drive
- Suite 301
- Cambridge, MA 02140
- United States
Corporate Office
- 125 Cambridgepark Drive
- Suite 301
- Cambridge, MA 02140
- United States
Lysoway Therapeutics Timeline
Lysoway Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 01-Jul-2026 | $3.4M | Completed | Clinical Trials - Phase 1 | ||
| 2. Grant | 05-Aug-2025 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC (Series A) | 05-Oct-2022 | $22M | $22M | Completed | Clinical Trials - General |
Lysoway Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Michael J. Fox Foundation | Limited Partner | |||
| 3E Bioventures Capital | Venture Capital | Minority | ||
| Highlight Capital | Venture Capital | Minority | ||
| Oceanpine Capital | Growth/Expansion | Minority |
Lysoway Therapeutics FAQs
-
When was Lysoway Therapeutics founded?
Lysoway Therapeutics was founded in 2020.
-
Where is Lysoway Therapeutics headquartered?
Lysoway Therapeutics is headquartered in Cambridge, MA.
-
What industry is Lysoway Therapeutics in?
Lysoway Therapeutics’s primary industry is Drug Discovery.
-
Is Lysoway Therapeutics a private or public company?
Lysoway Therapeutics is a Private company.
-
What is Lysoway Therapeutics’s current revenue?
The current revenue for Lysoway Therapeutics is .
-
How much funding has Lysoway Therapeutics raised over time?
Lysoway Therapeutics has raised $22M.
-
Who are Lysoway Therapeutics’s investors?
Michael J. Fox Foundation, 3E Bioventures Capital, Highlight Capital, and Oceanpine Capital have invested in Lysoway Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process